Alzheimer's drug Leqembi has full FDA approval in the U.S. now and that means Medicare will pay for it

1079951010

U.S. officials granted full approval to a closely watched Alzheimer's drug on Thursday, clearing the way for Medicare and other insurance plans to begin covering the treatment for people with the brain-robbing disease.



from CBC | Health News https://ift.tt/kTMoVUs

Aucun commentaire:

Enregistrer un commentaire